Chan Henry Lee

SVP, General Counsel

Chan Henry Lee (SVP, General Counsel) filed 15 Form 4 reports in the trailing twelve months (0 purchases, 15 sales), most often in BeOne Medicines AG (ONC). The largest single filing was $3.7M of ONC (10,671 sh across 4 lots, as filed), executed Oct 8 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 15 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$7.9M

shares × price, as filed

Last traded

Aug 11

Filed Aug 13

Median ADV $130.5M across their filed names

Open performance→

Volume by month

Buys $0 Sells $15.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 15 filings

Sector per market data · by filing · past 12 months

Most traded names

ONC

BeOne Medicines AG ONC · 0 buys · 20 sells 20 filings BGNE BGNE BGNE · 0 buys · 3 sells 3 filings

Recent filings

ONCSALE BeOne Medicines AG View filing → $3.3M
11,013 sh across 3 lots
Exec Aug 13 2025
Filed Aug 15 2025 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $280K
920 sh × $304.60
Exec Jul 30 2025
Filed Jul 31 2025 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $112K
422 sh × $266.50
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $120K
470 sh × $255.78
Exec Jun 6 2025
Filed Jun 10 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. View filing → $331K
1,205 sh × $275.00
Exec Feb 27 2025
Filed Mar 3 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. View filing → $284K
1,102 sh across 2 lots
Exec Feb 21 2025
Filed Feb 25 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. View filing → $285K
1,202 sh × $237.10
Exec Sep 30 2024
Filed Oct 2 2024 · 5:30 PM ET